US Food & Drug Administration Oncology Center of Excellence Director Richard Pazdur thinks the time is right to simplify the number of “expedited” pathways that FDA and drug sponsors use as part of the regulatory process.
Pazdur has emphasized that point as part of an initiative launched by Friends of Cancer Research last fall to build...